These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 23034699

  • 1. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.
    Stevens JW, Simpson E, Harnan S, Squires H, Meng Y, Thomas S, Michaels J, Stansby G.
    Br J Surg; 2012 Dec; 99(12):1630-8. PubMed ID: 23034699
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness of cilostazol, naftidrofuryl oxalate, and pentoxifylline for the treatment of intermittent claudication in people with peripheral arterial disease.
    Meng Y, Squires H, Stevens JW, Simpson E, Harnan S, Thomas S, Michaels J, Stansby G, O'Donnell ME.
    Angiology; 2014 Mar; 65(3):190-7. PubMed ID: 23378195
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
    Guest JF, Davie AM, Clegg JP.
    Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pentoxifylline for intermittent claudication.
    Broderick C, Forster R, Abdel-Hadi M, Salhiyyah K.
    Cochrane Database Syst Rev; 2020 Oct 16; 10(10):CD005262. PubMed ID: 33063850
    [Abstract] [Full Text] [Related]

  • 10. The limits of evidence in drug approval and availability: a case study of cilostazol and naftidrofuryl for the treatment of intermittent claudication.
    Hong H, Mackey WC.
    Clin Ther; 2014 Aug 01; 36(8):1290-301. PubMed ID: 25012728
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pentoxifylline for intermittent claudication.
    Salhiyyah K, Forster R, Senanayake E, Abdel-Hadi M, Booth A, Michaels JA.
    Cochrane Database Syst Rev; 2015 Sep 29; 9(9):CD005262. PubMed ID: 26417854
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials.
    Regensteiner JG, Ware JE, McCarthy WJ, Zhang P, Forbes WP, Heckman J, Hiatt WR.
    J Am Geriatr Soc; 2002 Dec 29; 50(12):1939-46. PubMed ID: 12473004
    [Abstract] [Full Text] [Related]

  • 17. Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data.
    De Backer T, Vander Stichele R, Lehert P, Van Bortel L.
    BMJ; 2009 Mar 10; 338():b603. PubMed ID: 19276131
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.